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ca. patients treated in our institution. First, pattern statistics 
were compared to population data in literature to establish 
validity of the data used for testing. Second, patterns 
representing highest irregularity were selected: variance in 
amplitude (1), periodicity (2), and a pattern with a baseline 
drift (3). A periodical computer generated sinusoid (4) was 
used for comparison.  
Patterns were fed into a QUASAR™ Respiratory Motion 
Phantom (Modus Medical), with “lung tumour insert” 
(cork/polystyrene). Each pattern was scanned 5 times using a 
16 slice lightspeed RT series scanner (General Electric). 
“Lung tumour” contours were extracted using auto 
segmentation of average (AVE) and MIP CT data. Contour 
volumes were compared using Dice coefficients (DC) and to 
expected volumes. 
 
Results: The average breathing amplitude in our patient 
population was 8.70± 3.0 mm. The average period was 3.99 ± 
1.0 seconds per breath. Both compared well with literature 
values.  
Based on repeat CT data, DC was ≥ 0.90 for group ( 1) and (3) 
and (4). However, DC for group 2 (‘irregular periodicity), was 
only 0.83, which is significantly lower (p=0.002). Computed 
volumes were nearer to expected volumes using AVE CT, but 
using AVE CT always leads to underestimation. Volumes 
computed in MIP CT reconstructions cover the expected 
volumes better, but there is a chance of overestimation of up 
to 20% in volume. 
 
Conclusion: Even though 4D CT scanning has been around 
quite some time, this is one of the first studies to address the 
effects of clinically found breathing irregularities. The 
selected test data seem to be adequate for lung ca. patients, 
and selected types of irregularities are commonly seen by 
therapists operating CT scanner and linac. 
The study indicates that irregular respiratory patterns 
introduce the element of “chance” in the position and size of 
delineated tumour volumes, depending on amount and type 
of irregularity. Therefore, it is recommended to always take 
into account effect of breathing pattern irregularity in 
scanning and treatment planning for lung tumours. 
Since 4D imaging typically consists of scanning while tracking 
a marker position, the recommendation probably holds for 
every CT scanner used in radiotherapy, and possibly also for 
PET and MRI scanners. 
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Purpose or Objective: Most institutes use the ITV approach 
to account for breathing motion into treatment planning, 
generally yielding too large treatment volumes. Recent 
publications showed that use of a mid-ventilation CT (midV-
CT, representing the mean breathing phase) and treating 
remaining breathing motions as a random error, led to high 
tumor control and overall survival for hypo-fractionated 
treatments. However, the midV-CT is not available 
commercially yet. In this work we perform a marker-based 
validation of our open-source software to generate a midV-CT 
for upper abdomen cancer patients. 
 
Material and Methods: Planning data from 12 upper 
abdominal cancer patients (8 liver- and 4 pancreatic 
patients) were used for this study. These patients were 
treated with the ITV approach using hypo-fractionated 
schemes (ranging from 5x7.5 Gy to 1x24 Gy). Each patient 
had a gold marker implanted close to the CTV center of mass 
(COM). 4DCT data consisted of 10 amplitude-based breathing 
phases (CT BrillianceTM, Phillips). In our planning system 
(EclipseTM,Varian), the position of the marker was measured 
by hand for each breathing phase and patient. In the open- 
source medical imaging 3DSlicer, B-spline deformable 
registration was used to register the plan CT and the 
different phases of the 4DCT. The resulting transformation 
matrices were then used by our 3DSlicer modules to 
automatically generate the midV-CT and the COM motions of 
any planning volume or marker. Subsequently, the marker 
position in the midV-CT was compared to the average marker 
position in Eclipse. Furthermore, the Eclipse marker motion 
curves and amplitudes were compared with the marker and 
CTV motions from 3DSlicer. Additionally, treatments plans 
were generated for one patient using the midV-CT and 
compared with our ITV-based clinical plan. 
 
Results: The mean CTV volume was 24.7±22.0 cc (1SD) and 
the mean marker to CTV COM distance was 12.7±6.2mm 
(1SD). The midV CTs are generated by 3DSlicer within 30 
minutes using a PC. Motion validation results are shown in 
Table 1. Differences in the mean COM of the marker in 
Eclipse and in midV-CT are within 1 mm, indicating an 
accurate midV-CT generation by our software. Average 
amplitude differences are within 1 mm but Eclipse motions 
tend to be slightly larger, possibly due to the uncertainty of 
manually finding the marker in the 4D phases. 
Correspondingly, RMS differences between motion curves of 
Eclipse and 3DSlicer were therefore 0.2-0.6 mm, whereas the 
RMS differences between marker and CTV motion in 3DSlicer 
only 0.1-0.2 mm (Fig 1a). The latter suggests that well-
placed markers can estimate CTV motions. Fig 1b shows 
differences in dose volume histograms between the ITV and 
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Conclusion: Accurate midV-CT can be generated using 
freeware. This opens the prospect for its use in our clinical 
practice, allowing treatments in the upper abdomen with 
more adequate CTV-to-PTV margins. For lung cancer patients 
the approach should work even better due to the higher 
contrast images. 
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Purpose or Objective: Radiotracer uptake patterns in FDG-
PET through computation of textural features vcan be used to 
improve characterization of lung cancer lesions for disease 
prognostication and response monitoring and tumor 
delineation purposes. Respiratory motion artefacts cause 
lesion blurring resulting in loss of intra-tumour 
heterogeneity. We have investigated the effect of respiratory 
gating on the recovery of intra-tumour heterogeneity. 
 
Material and Methods: FDG-PET/CT imaging was performed 
in 70 lung cancer patients. Amplitude-based optimal 
respiratory gating (ORG) was performed on bed positions 
covering the thorax. The duty cycle (percentage of the total 
PET data) used for image reconstruction of ORG images was 
35%. Non-gated images were reconstructed using 126 seconds 
of PET data, yielding similar noise characteristics as ORG. 
Lesion segmentation was performed using the fuzzy locally 
adaptive Bayesian (FLAB) algorithm. Four heterogeneity 
parameters (entropy, dissimilarity, zone percentage (ZP), and 
high energy emphasis (HIE)), which have previously shown to 
be robust and associated with survival in lung cancer, were 
calculated in non-gated and ORG images.  
 
Results: Respiratory gating did not result in statistically 
significant differences in the heterogeneity parameters. Sub-
group analysis revealed a significant effect of ORG on the 
heterogeneity parameters of lesions in the lower lobes. The 
mean increase for entropy, dissimilarity, ZP and HIE, 
considering lesions in the lower lobes was 1.3±1.5% (p=0.02), 
11.6±11.8% (p=0.006) 2.3±2.2% (p=0.002), and 16.8%±17.2% 
(p=0.006) respectively. For the centrally located lesions, the 
mean increase for entropy, dissimilarity, ZP and HIE was 
0.58±3.7% (p=0.6), 5.0±19.0% (p=0.4) 0.59±4.0% (p=0.9), and 
4.4±27.8% (p=0.4), respectively. Lesions in the upper lobes 
showed a mean increase of -0.35±1.8 (p=0.3), -1.0±7.7% 
(p=0.3), -0.4±2.7% (p=0.5), -1.7±13.2% (p=0.4), for entropy 
dissimilarity, ZP and HIE, respectively. There was no 
significant correlation between lesion volume and the change 
in parameters between non-gated and ORG images. 
 
Conclusion: Results from this study indicate that ORG 
significantly impacts characterisation of intra-tumour 
heterogeneity, particularly for lesions in the lower lung 
lobes. This suggests that adequate management of 
respiratory motion artefacts is important for improving 
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Purpose or Objective: Developing a radiobiologically 
consistent model predicting individual outcome for rectal 
cancer patients (RCPs) treated with an adaptive boost 
approach during neo-adjuvant radiochemotherapy (RCH). 
 
Material and Methods: Forty-two RCPs were treated within a 
prospective observational study. CH consisted of oxaliplatin 
(on days: -14, 0, 14) and 5-fluorouroacil (from day -14 to end) 
being day 0 the start of RT. All patients were treated with 
Helical Tomotherapy (18x2.3Gy) with an adaptive 
concomitant boost technique delivering 3Gy/fr on the 
residual gross tumor volume (GTV) in the last 6 fractions (fr), 
based on MRI imaging taken at fr 9. GTVs were contoured by 
a single radiologist on axial T2 MRI images acquired for initial 
planning (V_PRE), at fr 9 for the adaptive planning (V_MID) 
and before surgery, after a median time of 8.9 weeks after 
the end of RCH (V_POST). Based on a Poisson-like tumor 
regression model and neglecting repopulation and inter-
patient variability of the removal kinetics of killed cells, the 
parameter (1-ΔV(D))^V_PRE was taken as a surrogate of 
tumor control probability (TCP), where ΔV(D)=V_MID/V_PRE 
or V_POST/V_PRE, considering D at fr 9 (TCP_MID) or at the 
end of RCH (TCP_POST). The discriminative power of 
TCP_MID/POST in predicting the pathological complete 
remission (pCR, n=14) was assessed by the AUC of the 
corresponding ROC curves. Then, two-variables logistic (LOG) 
models including V_PRE and ΔV(D) as covariates were also 
considered and the ROC curves of the four models 
(TCP_MID,TCP_POST,LOG_MID, LOG_POST) were compared. 
In addition, an estimate of the residual cells at surgery (V_S) 
was robustly taken as the product of the pathologically 
assessed fraction of viable cells and V_POST. Spearman 
correlation rank test was used to evaluate the correlation 
between the models and V_S. 
 
Results: All models showed a high discriminative power in 
predicting pCR (p-value<0.0001). AUCs for TCP_ MID was 0.87 
(specificity: 71.4%, sensitivity: 96.4%, best cut-off: 5.85), 
higher than TCP_POST (0.82), although the difference did not 
reach significance (p=0.18). TCP_MID/TCP_POST were also 
highly correlated with V_S (R=0.77 and 0.74,p<0.0001). 
Similar performances were found for LOG_MID/LOG_POST 
with AUC=0.90/0.87 and R=0.79/0.77. No significant 
differences were found when comparing TCP models against 




Conclusion: A radiobiologically consistent model including 
early regression (TCP_MID) measured on T2-MRI images well 
predicts pCR and is strongly correlated with the estimated 
residual cells number after adaptive RCH; similar 
performances were obtained with a logistic model including 
V_PRE and V_MID/V_PRE. The corresponding models using 
V_POST showed a slightly, statistically not significant, worse 
